This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Drugs » Avandia

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

More Evidence Actos and Avandia Increases Risk of Bone Fracture

Posted: Monday, August 09, 2010

The popular diabetes drugs Actos and Avandia boost the risk of fracture in older women, according to findings from a new study that echo those of earlier research.

FDA Advisory Committee Votes to Keep Rosiglitazone on the Market

Posted: Sunday, July 25, 2010

Thirty-three members of the US Food and Drug Administration (FDA) cast 20 votes for various label options that would allow GlaxoSmithKline's rosiglitazone (Avandia) to stay on the market despite concerns over associated heart risks, while 12 members voted to recommend that the FDA withdraw the drug.

Diabetes and Cardiology Groups Stay Firm on Rosiglitazone

Posted: Sunday, July 04, 2010

In response to new Medicare data showing greater elevations in stroke, heart failure, and death risk with rosiglitazone compared with pioglitazone (Actos), the AHA issued a statement to the media reiterating its stance that there are insufficient data to support the choice of one over the other. And both the AHA and the ADA emphasized the need for patients to be informed of the new evidence, but not to panic.

TZD Patients Are 50% More Likely to Develop Bone Fractures

Posted: Sunday, March 07, 2010

A Henry Ford Hospital study finds women with Type 2 diabetes who take a commonly prescribed class of medications called TZD's to treat insulin resistance may be at a higher risk for developing bone fractures within 1 year of taking the medication.

FDA Reviewers Urge Pulling Rosiglitazone

Posted: Sunday, February 28, 2010

Two FDA reviewers have recommended that the diabetes drug rosiglitazone (Avandia) be pulled from the market because of its link to major cardiac events.

Diabetes Drug Avandia: Off the Market! FDA Documents, Senate Committee

Posted: Saturday, February 20, 2010

Controversial medicine raises users' heart risk, leaked files suggest.

Stopping Avandia Increases Blood Sugar Levels

Posted: Wednesday, April 29, 2009

Study found diabetics who discontinued use of the drug showed a worsening of control and management of their diabetes.

Liraglutide Has Low CVD Risk but May Be Blocked for Approval

Posted: Wednesday, April 15, 2009

Tumor data may block approval for diabetes drug liraglutide. An FDA advisory panel declined to recommend approval for the investigational diabetes drug liraglutide (Victoza), in light of animal studies linking the injection to thyroid cancer.

Thiazolidinediones Increase Fracture Risk in Women

Posted: Friday, December 12, 2008

Two widely prescribed type 2 diabetes drugs have recently been shown to increase risk of fractures in women, following long-term usage.

Rosiglitazone More Dangerous Than Pioglitazone for Elderly Diabetics

Posted: Monday, November 24, 2008

Two oral medications for type 2 diabetes, rosiglitazone and pioglitazone, have both been shown to have benefit and potentially high risk. A recent study has concluded that rosigilitazone is significantly more dangerous for older diabetics.